NCT05801627View on ClinicalTrials.gov

SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled by Metformin

PHASE3CompletedINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

May 6, 2020

Primary Completion Date

May 24, 2022

Study Completion Date

May 24, 2022

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

SAL067

SAL067 6mg(2 tablet) and Metformin ≥1500mg

DRUG

Placebo

Placebo (2 tablet) and Metformin ≥1500mg

Trial Locations (1)

Unknown

Peking University Hospital, Beijing

All Listed Sponsors
lead

Shenzhen Salubris Pharmaceuticals Co., Ltd.

INDUSTRY

NCT05801627 - SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled by Metformin | Biotech Hunter | Biotech Hunter